ArticleProceedings of the National Academy of Sciences of the United States of America2022

Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients.

Rebecca Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.